Repligen Corp (RGEN)
139.51
+0.90
(+0.65%)
USD |
NASDAQ |
Nov 04, 16:00
139.51
0.00 (0.00%)
After-Hours: 20:00
Repligen Revenue (Quarterly): 154.07M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 154.07M |
| March 31, 2024 | 151.35M |
| December 31, 2023 | 155.74M |
| September 30, 2023 | 141.19M |
| June 30, 2023 | 159.17M |
| March 31, 2023 | 182.66M |
| December 31, 2022 | 186.76M |
| September 30, 2022 | 200.74M |
| June 30, 2022 | 207.63M |
| March 31, 2022 | 206.40M |
| December 31, 2021 | 186.52M |
| September 30, 2021 | 178.22M |
| June 30, 2021 | 162.96M |
| March 31, 2021 | 142.84M |
| December 31, 2020 | 108.65M |
| September 30, 2020 | 94.06M |
| June 30, 2020 | 87.46M |
| March 31, 2020 | 76.09M |
| December 31, 2019 | 69.47M |
| September 30, 2019 | 69.44M |
| June 30, 2019 | 70.69M |
| March 31, 2019 | 60.63M |
| December 31, 2018 | 51.94M |
| September 30, 2018 | 49.53M |
| June 30, 2018 | 47.73M |
| Date | Value |
|---|---|
| March 31, 2018 | 44.83M |
| December 31, 2017 | 41.61M |
| September 30, 2017 | 36.58M |
| June 30, 2017 | 32.46M |
| March 31, 2017 | 30.59M |
| December 31, 2016 | 25.60M |
| September 30, 2016 | 24.68M |
| June 30, 2016 | 29.17M |
| March 31, 2016 | 25.09M |
| December 31, 2015 | 21.45M |
| September 30, 2015 | 19.81M |
| June 30, 2015 | 21.46M |
| March 31, 2015 | 20.82M |
| December 31, 2014 | 16.39M |
| September 30, 2014 | 15.28M |
| June 30, 2014 | 15.55M |
| March 31, 2014 | 16.33M |
| December 31, 2013 | 15.38M |
| September 30, 2013 | 18.82M |
| June 30, 2013 | 17.51M |
| March 31, 2013 | 16.46M |
| December 31, 2012 | 18.81M |
| September 30, 2012 | 15.10M |
| June 30, 2012 | 15.52M |
| March 31, 2012 | 12.82M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
69.47M
Minimum
Dec 2019
207.63M
Maximum
Jun 2022
150.10M
Average
155.74M
Median
Dec 2023
Revenue (Quarterly) Benchmarks
| West Pharmaceutical Services Inc | 746.90M |
| QuidelOrtho Corp | 637.00M |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 29.94M |
| Catheter Precision Inc | 0.093M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.321M |
| Total Expenses (Quarterly) | 152.59M |
| EPS Diluted (Quarterly) | 0.06 |
| Enterprise Value | 7.541B |
| Gross Profit Margin (Quarterly) | 49.82% |
| Profit Margin (Quarterly) | 2.16% |
| Earnings Yield | -0.03% |
| Normalized Earnings Yield | -0.5422 |